Systemic Sclerosis
📧 Sign up to get email alerts when something new happens for Systemic Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: Zibotentan Better Renal Scleroderma Outcome Study [Phase 2]
Phase 2 trial evaluating Zibotentan for renal outcomes in systemic sclerosis (scleroderma) has completed, with results summarized in this up…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma [NA]
This completed clinical trial evaluated novel rehabilitation strategies to improve arm function in patients with systemic sclerosis (sclerod…
-
CLINICAL_TRIALS trial_result · 2017-10-04Clinical Trial Update: Nilotinib in the Treatment of Systemic Sclerosis [Phase 2]
Phase 2 clinical trial on nilotinib for systemic sclerosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis [Phase 4]
Phase 4 clinical trial update evaluating ambrisentan and tadalafil in pulmonary arterial hypertension associated with systemic sclerosis; st…
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: The Effect of Ethanol Extract Physalis Angulata Linn. in Scleroderma Patients With Standard Therapy [NA]
Completed clinical study evaluating an ethanol extract of Physalis angulata in systemic sclerosis patients receiving standard therapy; no re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial [Phase 1, Phase 2]
The update reports completion of a Phase I/II biomarker and safety trial of topical C-82 for systemic sclerosis (scleroderma).
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Psychological Treatments for Scleroderma [Phase 2]
A Phase 2 trial evaluating psychological treatments for systemic sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-14Clinical Trial Update: Scleroderma: Cyclophosphamide or Transplantation [Phase 2, Phase 3]
Phase 2/3 trial update comparing cyclophosphamide versus transplantation in systemic sclerosis (scleroderma) completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis [Phase 1, Phase 2]
The document reports the termination of a Phase 1/2 clinical trial evaluating UVA1 irradiation for early skin fibrosis in systemic sclerosis…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2330811 in healthy subjects, with systemic sclero…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis
A completed clinical trial examining swallowing difficulties during medication intake in patients with systemic sclerosis and evaluating cop…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Vasculopathy, Inflammation and Systemic Sclerosis [NA]
This update notes the completed status of a clinical trial addressing vasculopathy and inflammation in systemic sclerosis conducted by Unive…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Oral Health and People With Systemic Sclerosis
ClinicalTrials.gov notes the completion of a trial studying oral health in people with systemic sclerosis, sponsored by the University of Al…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Gastroesophageal Reflux Treatment in Scleroderma [Phase 3]
Phase 3 trial evaluating treatment for gastroesophageal reflux disease in patients with scleroderma/systemic sclerosis has completed with re…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers [Phase 2]
A Phase 2 trial comparing diltiazem gel to nitroglycerin ointment for healing digital ulcers in systemic sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma). [NA]
A completed clinical trial evaluated an oral medication for treatment and prevention of digital ulcers in systemic sclerosis (scleroderma). …
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II) [Phase 2]
This update summarizes the results of a Phase 2 randomized trial (Scleroderma Lung Study II) comparing regimens for systemic sclerosis-assoc…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud [EARLY_Phase 1]
The document notes completion of an early Phase 1 trial comparing topical 10% nifedipine with 5% sildenafil for secondary Raynaud's phenomen…
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome [Phase 3]
Phase 3 clinical trial completed evaluating the efficacy of botulinum toxin for scleroderma-associated Raynaud's phenomenon; results posted.
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension
This clinical trial update indicates the study examining endothelial microparticles in systemic sclerosis-associated pulmonary hypertension …
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis [Phase 3]
Phase 3 trial evaluating sildenafil for improving microcirculatory blood flow and endothelial progenitor cell levels in systemic sclerosis h…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis
This clinical trial update reports on a completed study examining stimulatory autoantibodies to the platelet-derived growth factor receptor …
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc) [EARLY_Phase 1]
Early Phase 1 trial evaluating the long-term effects of buspirone on esophageal function and esophageal symptoms in patients with systemic s…
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: SCLERoderma et Adipose-DErived Stroma Cells [Phase 2]
Phase 2 clinical trial evaluating adipose-derived stromal cells for systemic sclerosis; current status of the trial is unknown.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Effect of Bosentan in Scleroderma Renal Crisis [Phase 2]
Phase 2 trial evaluating bosentan for scleroderma renal crisis has completed.